![Klaus Veitinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Klaus Veitinger
Vorsitzender bei
Neurogastrx, Inc.
Profil
Dr. Klaus R.
Veitinger is a Chairman at Promentis Pharmaceuticals, Inc., a Venture Partner at OrbiMed Advisors Private Equity, a Chairman at Neurogastrx, Inc. and a Chairman at Sparrow Pharmaceuticals, Inc. Dr. Veitinger was previously employed as an Independent Director by scPharmaceuticals, Inc., a Chairman by Tricida, Inc., a Chairman by Symbiomix Therapeutics LLC, an Independent Director by Intercept Pharmaceuticals, Inc., a Vice Chairman by Relypsa, Inc., a President & Chief Executive Officer by Schwarz Pharma, Inc., and a Member-Management Board by Schwarz Pharma AG.
He also served on the board at Chroma Therapeutics Ltd., Biolex Therapeutics, Inc., Bone Care International, Inc., Gelesis, Inc. and Pharmaceutical Research & Manufacturers of America.
He received his MBA from INSEAD and a doctorate degree from Heidelberg University (Ohio).
Aktive Positionen von Klaus Veitinger
| Unternehmen | Position | Beginn |
|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01.01.2007 |
Promentis Pharmaceuticals, Inc.
 Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neuropsychiatric disorders | Vorsitzender | 01.04.2008 |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Vorsitzender | 04.01.2018 |
Sparrow Pharmaceuticals, Inc.
 Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | - |
CranioVation, Inc.
 CranioVation, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services, which incudes severe neurological problems | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Klaus Veitinger
| Unternehmen | Position | Ende |
|---|---|---|
| SCPHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 07.10.2025 |
| TRICIDA, INC. | Vorsitzender | 01.06.2023 |
| INTERCEPT PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2016 |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Vorstandsvorsitzender | 01.12.2015 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Klaus Veitinger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Developed innovative therapeutic and pharmaceutical products | Health Technology |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Develops and produces drugs | Distribution Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Promentis Pharmaceuticals, Inc.
Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for neuropsychiatric disorders | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Health Technology |
Heidelberg University (Ohio)
 Heidelberg University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
CranioVation, Inc.
CranioVation, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services, which incudes severe neurological problems | Health Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Sparrow Pharmaceuticals, Inc.
Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
